Related Funds
Fund Name | Location |
Alarm.com | United States, Vienna, Virginia |
Arm Accelerator | Beijing, Beijing, China |
Boomerang-Catapult | - |
CenterPoint Energy | Houston, Texas, United States |
Flanders Innovation and Entrepreneurship (VLAIO) | Belgium, Brussels-Capital, City of Brussels |
Grand Yangtze Capital | China, Shanghai |
GreyBird Ventures | Concord, Massachusetts, United States |
Hongzhi Capital | China, Guangdong, Shenzhen |
IRDI SORIDEC Gestion | - |
Mid-Atlantic Venture | District of Columbia, United States, Washington |
MMC Capital Communications & Information Fund | Connecticut, Greenwich, United States |
N Capital Partners | - |
Shanghai Crop Capital Management Center | China, Shanghai |
Shanghai Xiangyun Economic Development | China, Qingpu, Shanghai |
W2 Labs | England, London, United Kingdom |
Wilbur-Ellis | California, San Francisco, United States |
XBOTPARK Jijin | - |
Young & Rubicam | New York, New York, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Cicheng Technology | 09 Oct 2024 | Jiangjin, Chongqing, China | |||
Ensurge Medical | $15M | 19 Aug 2024 | Suzhou, Jiangsu, China | ||
MoXin | 11 Apr 2024 | Futian District, Guangdong Province, China | |||
Xffuture | $15M | 09 Apr 2024 | Chengdu, Sichuan, China | ||
Delova Biotech | $15M | 02 Apr 2024 | - | ||
KINWIN | 29 Mar 2024 | Nanjing, Jiangsu, China | |||
Talent Today | $15M | 23 Feb 2024 | Futian, Guangdong, China | ||
Jinqirui Biology | 22 Aug 2023 | Huangpu, Shanghai, China | |||
Yunsheng Group | $41M | 24 Jun 2022 | Shanghai, Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Cicheng Technology | 09 Oct 2024 | Jiangjin, Chongqing, China | |||
Ensurge Medical | $15M | 19 Aug 2024 | Suzhou, Jiangsu, China | ||
MoXin | 11 Apr 2024 | Futian District, Guangdong Province, China | |||
Xffuture | $15M | 09 Apr 2024 | Chengdu, Sichuan, China | ||
Delova Biotech | $15M | 02 Apr 2024 | - | ||
KINWIN | 29 Mar 2024 | Nanjing, Jiangsu, China | |||
Talent Today | $15M | 23 Feb 2024 | Futian, Guangdong, China | ||
Jinqirui Biology | 22 Aug 2023 | Huangpu, Shanghai, China | |||
Yunsheng Group | $41M | 24 Jun 2022 | Shanghai, Shanghai, China |